cagrilintide semaglutide trade names GLP-1 single, dual, and triple receptor agonists for treating type 2 diabetes and obesity: a narrative review GLP-1 Receptor Agonists and Other

Both companies are adopting a wait-and-see attitude toward full supply due to global demand and production capacity constraints

Diabetes Obes Metab 2009, 11: Pratley RE, Nauck M, Bailey T, Montanya E, Cuddihy , Filetti S, Thomsen AB, Sondergaard RE, Davies M

using a nationwide commercial administrative claims database between 2005 and 2021, the use of GLP-1 RAs in patients with T2DM, as compared to that of dipeptidyl peptidase IV (DPP-IV) inhibitors (gliptins), has not been shown to be associated with an increased risk of pulmonary complications after EGD [26]

2011 Oct;41(9):248-53

Is Weight Watchers still the household name and weight loss or an example of a bygone approach to treating obesity